| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 728988 | 34009_499_140_1_2_IP2 | BILAXTEN 20 mg COMPRIMIDOS | BILAXTEN 20 mg COMPRIMIDOS, 20 comprimidos | 20 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/34009_499_140_1_2_IP2/34009_499_140_1_2_IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | ELAM PHARMA LABS S.L. | 2020-07-24 | 1 | 1 | 1 | 2020-07-25 | 2020-07-24 | 0 | 2023-11-21 | View Edit Delete | ||||||||||||
| 728857 | 1181334001 | VABOREM 1 G/1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | VABOREM 1 G/1 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 6 viales | 1.000 mg/1.000 mg | 45 | 6 | 34 | 6 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181334001/1181334001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181334001/1181334001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1801 | LABORATORIOS MENARINI S.A. | 2020-06-30 | 1 | 1 | 1 | 2020-07-01 | 2020-06-30 | 1 | 2021-05-13 | View Edit Delete | ||||||||||||
| 730337 | 5350178 | IXIA PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | IXIA PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/5350178/5350178_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | ECOFAR PRODUCTOS S.L. | 2021-02-09 | 1 | 1 | 1 | 2021-02-10 | 2021-02-09 | 1 | 2021-03-31 | View Edit Delete | ||||||||||||
| 729357 | 037109360IP | IXIA PLUS 40/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | IXIA PLUS 40/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-10-06 | 1 | 1 | 1 | 2020-10-07 | 2020-10-06 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729519 | 037109244IP | IXIA PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | IXIA PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-10-16 | 1 | 1 | 1 | 2020-10-17 | 2020-10-16 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729661 | BE390564 | BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK PLUS 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-03 | 1 | 1 | 1 | 2020-11-04 | 2020-11-03 | 1 | 2021-03-29 | View Edit Delete | ||||||||||||
| 729662 | 036025118 | OPENVAS 40 mg COMPRIMIDOS RECUBIERTOS | OPENVAS 40 mg COMPRIMIDOS RECUBIERTOS, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-03 | 1 | 1 | 1 | 2020-11-04 | 2020-11-03 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729672 | BE390503 | BALZAK PLUS 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK PLUS 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-04 | 1 | 1 | 1 | 2020-11-05 | 2020-11-04 | 1 | 2021-03-29 | View Edit Delete | ||||||||||||
| 729762 | 036026110IP2 | IXIA 40 mg COMPRIMIDOS RECUBIERTOS | IXIA 40 mg COMPRIMIDOS RECUBIERTOS, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-13 | 1 | 1 | 1 | 2020-11-14 | 2020-11-13 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729834 | 037108242IP1 | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-24 | 1 | 1 | 1 | 2020-11-25 | 2020-11-24 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729859 | 037108368IP | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2020-11-27 | 1 | 1 | 1 | 2020-11-28 | 2020-11-27 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 730074 | 038947139IP | BALZAK 40mg/5mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK 40mg/5mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40mg/5mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2021-01-08 | 1 | 1 | 1 | 2021-01-09 | 2021-01-08 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 730075 | 038947242IP | BALZAK 40mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BALZAK 40mg/10mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2021-01-08 | 1 | 1 | 1 | 2021-01-09 | 2021-01-08 | 1 | 2021-02-01 | View Edit Delete | ||||||||||||
| 729670 | 037108368 | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/037108368/037108368_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | DIFARMED S.L.U. | 2020-11-04 | 1 | 1 | 1 | 2020-11-05 | 2020-11-04 | 1 | 2021-02-05 | View Edit Delete | ||||||||||||
| 729795 | 037108242IP | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/037108242IP/037108242IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | DIFARMED S.L.U. | 2020-11-20 | 1 | 1 | 1 | 2020-11-21 | 2020-11-20 | 1 | 2021-02-05 | View Edit Delete | ||||||||||||
| 730757 | 1-21520 | LOBIVON 5 MG COMPRIMIDOS | LOBIVON 5 mg COMPRIMIDOS, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2021-04-06 | 1 | 1 | 1 | 2021-04-07 | 2021-04-06 | 1 | 2021-06-29 | View Edit Delete | ||||||||||||
| 731211 | 115989001 | TENKASI 400 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | TENKASI 400 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 3 viales | 400 mg | 45 | 3 | 34 | 3 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/115989001/115989001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/115989001/115989001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1801 | LABORATORIOS MENARINI S.A. | 2021-05-25 | 1 | 1 | 1 | 2021-05-26 | 2021-05-25 | 1 | 2022-07-26 | View Edit Delete | ||||||||||||
| 732445 | 038946137IP | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | No Disponible | No Disponible | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | MELYFARMA S.L. | 2021-12-15 | 1 | 1 | 1 | 2021-12-16 | 2021-12-15 | 1 | 2022-02-22 | View Edit Delete | ||||||||||||
| 758615 | 88177 | IBIS 6 MG/ML COLIRIO EN SOLUCION | IBIS 6 MG/ML COLIRIO EN SOLUCION, 1 frasco de 5 ml | 6 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88177/88177_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88177/88177_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | LABORATORIOS MENARINI S.A. | 2022-10-10 | 1 | 1 | 1 | 2022-10-11 | 2022-10-10 | 1 | 2023-08-02 | View Edit Delete | ||||||||||||
| 762384 | 08462003IP | RANEXA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA | RANEXA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA, 60 comprimidos | 500 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08462003IP/08462003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08462003IP/08462003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1801 | ECOFAR PRODUCTOS S.L. | 2023-03-08 | 1 | 1 | 1 | 2023-03-09 | 2023-03-08 | 1 | 2023-03-09 | View Edit Delete |
Page 276 of 1036, showing 20 records out of 20704 total, starting on record 5501, ending on 5520